Skip to main content

Table 1 Clinical characteristics by sex in the Baependi Heart Study

From: Cardiometabolic risk factors correlated with the incidence of dysglycaemia in a Brazilian normoglycaemic sample: the Baependi Heart Study cohort

Variables

Men

Women

Baseline

5-year follow-up

p-value

Baseline

5-year follow-up

p-value

SBP (mmHg)

128.73 ± 18.0

128.32 ± 16.9

0.750

120.52 ± 17.3

123.30 ± 15.9

0.010

DBP (mmHg)

78.24 ± 11.3

77.47 ± 10.9

0.358

77.4 ± 10.7

76.08 ± 10.1

0.046

BMI (kg/m2)

23.16 ± 3.7

25.34 ± 4.6

< 0.001

25.01 ± 5.1

26.16 ± 5.3

< 0.001

WC (cm)

85.38 ± 10.9

91.01 ± 12.6

< 0.001

86.55 ± 12.2

91.59 ± 12.0

< 0.001

WHR

0.90 ± 0.08

0.94 ± 0.09

< 0.001

0.87 ± 0.08

0.92 ± 0.07

< 0.001

FBG (mg/dL)

81.27 ± 11.4

94.13 ± 20.9

< 0.001

79.85 ± 12.4

92.20 ± 21.3

< 0.001

TC (mg/dL)

172.85 ± 47.2

201.09 ± 42.0

< 0.001

177.63 ± 47.1

202.54 ± 89.0

< 0.001

HDL-c (mg/dL)

53.76 ± 14.9

45.49 ± 10.7

< 0.001

57.49 ± 15.7

48.79 ± 12.1

< 0.001

TC/HDL-c ratio

3.47 ± 1.56

4.61 ± 1.35

< 0.001

3.32 ± 1.31

4.36 ± 2.18

< 0.001

LDL-c (mg/dL)

92.78 ± 42.2

127.11 ± 35.9

< 0.001

95.8 ± 43.6

124.17 ± 35.1

< 0.001

TG (mg/dL)

132.5 ± 80.2

141.76 ± 88.5

0.137

125.10 ± 63.1

128.24 ± 66.9

0.448

  1. Results are expressed as mean ± standard deviation; comparisons are between baseline and 5-year follow-up in each sex
  2. Statistically significant p values are in italic (p < 0.05)
  3. SBP systolic blood pressure, DBP diastolic blood pressure, BMI body mass index, WC waist circumference, WHR waist hip ratio, FBG fasting blood glucose, TC total cholesterol, HDL-c high density lipoprotein cholesterol, TC/HDL-c total cholesterol:HDL-c ratio, LDL-c low density lipoprotein cholesterol; TG triglycerides
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us